LGR5 and neoplasm: This study has demonstrated that liver cancer contains an LGR5+ compartment that has various hallmarks of TICs/CSCs, including an increased capacity for tumor organoid formation in culture and allograft formation in mice, as well as resistance against conventional anticancer therapy.